Dulaglutide 0.75Mg/0.5Ml Inj Pen

DRUG2 trials

Sponsors

University of Pennsylvania, Ain Shams University

Conditions

Abnormal Glucose ToleranceCystic FibrosisDiabetesPancreatic InsufficiencyTransfusion Dependent Beta Thalassemia

Phase 2

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

RecruitingNCT04731272

University of PennsylvaniaAbnormal Glucose Tolerance, Cystic Fibrosis, Diabetes +1

Start: 2021-07-16End: 2028-06-30Target: 30Updated: 2026-05-18

Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

CompletedNCT07370922

Ain Shams UniversityTransfusion Dependent Beta Thalassemia

Start: 2024-11-22End: 2026-01-05Updated: 2026-01-27